Allopregnanolone (DrugBank: Allopregnanolone)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 205 | Fragile X syndrome related disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02603926 (ClinicalTrials.gov) | October 2015 | 5/11/2015 | Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone | Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone | Fragile X-associated Tremor/Ataxia Syndrome | Drug: Allopregnanolone | Randi J. Hagerman, MD | NULL | Completed | 50 Years | 85 Years | All | 6 | Phase 2 | United States |